Differential effect of clozapine on weight: a controlled study.
about
Clozapine versus typical neuroleptic medication for schizophreniaAcute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophreniaClozapine versus typical neuroleptic medication for schizophreniaAtypical antipsychotics: Part II: Adverse effects, drug interactions, and costs.Body weight gain induced by antipsychotic drugs: mechanisms and management.Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.Risk factors for obesity in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities.'Why getting fat, Doc?' Weight gain and psychotropic medications.Euglycemic clamp study in clozapine-induced diabetic ketoacidosis.Blood lactate levels in patients receiving first- or second- generation antipsychotics.Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents.Behavioural management of antipsychotic-induced weight gain: a review.Interventions for Weight Gain in Adults Treated With Novel Antipsychotics.Weight change with atypical antipsychotics in the treatment of schizophrenia.Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis.Assessing obesity and other related health problems of mentally ill Hispanic patients in an urban outpatient setting.A Longitudinal Study of Relation between Side-effects and Clinical Improvement in Schizophrenia: Is There a Neuro-metabolic Threshold for Second Generation Antipsychotics?Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal.The association between weight change and symptom reduction in the CATIE schizophrenia trial.Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophrenia.Contributing factors to weight gain during long-term treatment with second-generation antipsychotics. A systematic appraisal and clinical implications.Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.Metabolic changes associated with antipsychotic useLow Density Lipoprotein Receptor-Related Protein and Apolipoprotein E Expression is Altered in Schizophrenia.Association Between Weight Gain and Remission Status at 3 Months in First-Episode Schizophrenia.The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine.Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychoticsClozapine-associated weight loss.Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidone.Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic.Weight changes during clozapine treatment.The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment.Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study
P2860
Q24240931-9BF7EFD8-ADF0-4027-A065-1DC80948D822Q24798487-A4CF6BD0-9DAA-405B-8D1B-1C1601551552Q28143549-2F5DB72A-D4C9-4704-A8F8-389F8B73E616Q33543117-8AE28926-38EF-4A9D-AC21-84CCB78FE189Q33708467-AD19DF38-0C9C-4E80-A149-7C6297E4577FQ33988376-AF6BE262-F993-4511-A343-622C61471DCFQ34106516-54BFA691-66D8-4912-9509-DAE67F379702Q34230366-63E56E18-3436-4E2B-B565-8DD97402D40CQ34299393-A1E27DB5-4C2E-45C8-9B21-9D2AAE3B1ECBQ34449430-E662FD07-89E7-4D30-9187-96F7CD6C2C6EQ34613859-31573696-3CF7-4700-8ED1-386364BA8994Q35087431-B310EA68-1EC4-4EEF-A804-466F136AE6B6Q35212362-3C019813-0BE0-42FA-BBDB-FA30A6D2CDB1Q35664958-5EB79BAE-4662-47E1-9F25-F16DC5AE6F48Q36310286-9E0DE0A6-6327-41FB-A291-B260BC05962EQ36433993-82E8DD6B-8278-4625-9BD9-29D3D2ADAE54Q36785041-EF15149F-6239-4C79-AB5A-13AB0BE7DD76Q36832340-ED1014D2-D1E9-492E-9E55-328CEAC5A362Q37171035-C727276B-1ECD-4C87-9B8F-C79DE812DD4BQ37188995-CB086B05-9EB9-4D9A-8E73-F7A72F5E46B8Q37212106-F4BC9590-E360-499D-8DCD-E573E2B43195Q37224949-94E5625E-DA4F-4DC7-8BEE-00BEBDC52674Q37244634-286B4A32-614F-4B29-AD42-2C438E753B15Q37491329-FEDFD3A7-F43A-4017-8803-DCCCA5966BD1Q37865505-A1622F62-A183-400F-A5E9-990002FF0DF3Q41359319-E65AD545-8726-4B12-9112-A54EA07756BCQ41771932-FC42B9F9-8866-4973-8B8A-CD61CB7B236DQ42433433-8A7C601B-CBCB-4371-B8A7-839782158E11Q42506977-B2F93C54-8386-4408-AAAF-71755CAA4184Q42805312-FC25F1F6-B569-4B4B-86E2-FCFD801B795FQ46098816-066055A2-0F96-49F3-9B49-EEEE8B77D9FDQ46380164-3EE8C6DF-F4CE-4E1E-9029-7B4FE63BE316Q46798701-FE8C3AF0-0EEF-45C7-ACAA-FB6257121F9BQ47277973-5C601E3A-CFE0-4CCB-8322-A7C8670724AEQ49481418-3F7585FC-65BF-438B-BC6D-A73445A54BC8Q57709401-EE6EE758-8FBB-463F-8EAE-8AA3D1960A40
P2860
Differential effect of clozapine on weight: a controlled study.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Differential effect of clozapine on weight: a controlled study.
@en
Differential effect of clozapine on weight: a controlled study.
@nl
type
label
Differential effect of clozapine on weight: a controlled study.
@en
Differential effect of clozapine on weight: a controlled study.
@nl
prefLabel
Differential effect of clozapine on weight: a controlled study.
@en
Differential effect of clozapine on weight: a controlled study.
@nl
P2093
P356
P1476
Differential effect of clozapine on weight: a controlled study.
@en
P2093
P304
P356
10.1176/AJP.153.6.817
P407
P577
1996-06-01T00:00:00Z